Status:
COMPLETED
Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Pfizer
Conditions:
Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Our team is interested in what can be done to improve the functioning of patients who suffer from glaucoma, a chronic and irreversible eye disease. Patients with vision loss as a result of this diseas...
Detailed Description
Visual impairment, including both low vision and blindness, ranks among the ten most prevalent causes of disability in North America (1). Leading causes of low vision are diseases also associated with...
Eligibility Criteria
Inclusion
- Primary or secondary open angle glaucoma that has been stable for at least 12 months
- Presenting best corrected visual acuity (in the better seeing eye), measured at the screening visit, better than 20/400 but worse than 20/100 as a result of primary or secondary glaucoma.
- No surgical or laser procedures in the last 6 months
- The minimum number of degrees of central visual field (30-2 or 24-2 SITA threshold) should be no less than 20 degrees
Exclusion
- Has no access to telephone
- Is unable to speak English
- Has previously received comprehensive low vision services
- Has English literacy screening less than 5th grade level (Dolch Basic Sight Words List)
- Has history of stroke with aphasia
- Has other health condition that would preclude follow-up (e.g., significant malignancy or life-threatening disease)
- Is unable or unwilling to attend clinic visits required for the study
- Has severe hearing impairment that interferes with participation in telephone questionnaire
- Reports significant loss of vision since last eye exam
- Has macular degeneration, vitreous hemorrhage, serous or hemorrhagic detachment of the macula, clinically significant macular edema or cystoid macular edema that is likely to result in further loss or improvement in vision after treatment in better-seeing eye
- Planned cataract extraction within the next six months
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2015
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01262209
Start Date
May 1 2011
End Date
August 1 2015
Last Update
September 9 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ivey Eye Institute
London, Ontario, Canada, N6A 4V2